MedTrace Logo

High Resolution Optical Imaging of the Esophagus Using the NvisionVLE™ Imaging System

NCT02031900 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2014-03-26

No results posted yet for this study

Summary

This is a single center, single arm, open label observational trial of patients undergoing EGD. The primary objective of this clinical trial is to evaluate the ability of physicians to position the NvisionVLE Optical Probe to acquire an image of an area of the esophagus to identify and discriminate abnormal areas of tissue from normal.

Conditions

  • Undergoing Esophagogastroduodenoscopy (EGD)

Interventions

DEVICE

NvisionVLE Imaging System: NvisionVLE Imaging Console, NvisionVLE Optical Probe and Inflation Accessory Kit

The NvisionVLE Imaging System is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization.

Sponsors & Collaborators

  • NinePoint Medical

    lead INDUSTRY

Principal Investigators

  • Prashanthi Thota, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02031900 on ClinicalTrials.gov